SEQUENT SCIENTIFIC LTD.
Quaterly Results
Particulars | Dec 2023 | Sep 2023 | Jun 2023 | Mar 2023 |
---|---|---|---|---|
Audited / UnAudited | UnAudited | UnAudited | UnAudited | Audited |
Net Sales | 3293.59 | 3459.67 | 3332.08 | 3666.68 |
Total Expenditure | 3071.1 | 3308.36 | 3414.44 | 3700.36 |
PBIDT (Excl OI) | 222.49 | 151.31 | -82.36 | -33.68 |
Other Income | 45.18 | 16.48 | 7.93 | 17.37 |
Operating Profit | 267.67 | 167.79 | -74.42 | -16.31 |
Interest | 125.81 | 125.8 | 104.84 | 108.7 |
Exceptional Items | 27.6 | 80.67 | -235.11 | -615.96 |
PBDT | 169.46 | 122.66 | -414.38 | -740.97 |
Depreciation | 154.55 | 153.6 | 142.41 | 147.05 |
Profit Before Tax | 14.91 | -30.94 | -556.79 | -888.02 |
Tax | -91.85 | 37.88 | -209.98 | 36.38 |
Provisions and contingencies | NA | NA | NA | NA |
Profit After Tax | 106.76 | -68.82 | -346.81 | -924.4 |
Extraordinary Items | NA | NA | NA | NA |
Prior Period Expenses | NA | NA | NA | NA |
Other Adjustments | NA | NA | NA | NA |
Net Profit | 106.76 | -68.82 | -346.81 | -924.4 |
Minority Interest | -24.08 | -14.98 | -1.65 | -11.35 |
Shares of Associates | ||||
Other related items | ||||
Misc. Expenses Written off | NA | NA | NA | NA |
Consolidated Net Profit | 82.68 | -83.8 | -348.46 | -935.75 |
Equity Capital | 498.86 | 498.86 | 498.87 | 498.86 |
Face Value (IN RS) | 2 | 2 | 2 | 2 |
Reserves | NA | NA | NA | NA |
Calculated EPS | 0.33 | -0.33 | -1.39 | -3.75 |
Calculated EPS (Annualised) | 1.32 | -1.34 | -5.58 | -15.00 |
No of Public Share Holdings | 117753392 | 117753392 | 117753392 | 117753392 |
% of Public Share Holdings | 47.21 | 47.21 | 47.21 | 47.21 |
| NA | NA | NA | NA |
PBIDTM% (Excl OI) | 6.75 | 4.37 | -2.47 | -0.91 |
PBIDTM% | 8.12 | 4.84 | -2.23 | -0.44 |
PBDTM% | 5.14 | 3.54 | -12.43 | -20.20 |
PBTM% | 0.45 | -0.89 | -16.70 | -24.21 |
PATM% | 3.24 | -1.98 | -10.40 | -25.21 |
"; | Notes | Notes | Notes | Notes |